The Motley Fool

3 stocks I’d buy for this raging bull market

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Chart displaying growth
Image source: Getty Images.

Stocks are having a great run right now. Large-cap stocks are going up, small-caps stocks are going up… it really is a bit of a ‘goldilocks’ market.

Of course, stocks could pull back at any time. However, encouragingly, some experts believe the market could keep rising for a while. Wharton professor Jeremy Siegel, for example, believes stocks could keep rising until the US Federal Reserve moves to tighten rates. And he doesn’t believe that’s going to happen in the near term. “Enjoy this ride. It’s going to keep on going… toward the end of the year,” he told CNBC last week.

One Killer Stock For The Cybersecurity Surge

Cybersecurity is surging, with experts predicting that the cybersecurity market will reach US$366 billion by 2028more than double what it is today!

And with that kind of growth, this North American company stands to be the biggest winner.

Because their patented “self-repairing” technology is changing the cybersecurity landscape as we know it…

We think it has the potential to become the next famous tech success story. In fact, we think it could become as big… or even BIGGER than Shopify.

Click here to see how you can uncover the name of this North American stock that’s taking over Silicon Valley, one device at a time…

Here, I’m going to highlight three stocks I like for this bull market. I’d be happy to buy all three for my own portfolio today.


One FTSE 100 stock I believe has the potential to keep climbing in this bull market is alcoholic drinks giant Diageo (LSE: DGE).

My investment case here is pretty simple. As the world reopens in the months ahead, people are likely to catch up with their friends and drink alcohol. As the owner of a wide range of top brands such as Tanqueray and Guinness, Diageo should benefit.

This isn’t just a short-term play, however. In the long run, Diageo looks well-placed to benefit from the ‘premiumisation’ trend. Increasingly, consumers are willing to pay more for higher-quality products.

Of course, if there are Covid-19 setbacks, my investment case may become obsolete. However, with the stock still more than 10% below its all-time highs, I think the long-term risk/reward proposition here is attractive.


Another stock I’d buy for this bull market is US-listed Starbucks (NASDAQ: SBUX). This is a stock star portfolio manager Terry Smith bought for his fund last year.

I think this company should do well as lockdowns are eased globally. People are going to want to catch up with their friends so Starbucks should benefit. “We are here for that great human reconnection,” CEO Kevin Johnson said recently. “Starbucks was built for this moment.

However, Starbucks isn’t a cheap stock. Currently, it sports a forward-looking P/E ratio of about 40. This adds risk to the investment case. But I’m comfortable with the valuation as the company has historically been very profitable.

Smith & Nephew

Finally, I like Smith & Nephew (LSE: SN). This is a leading medical technology company specialising in joint replacements.

Smith & Nephew has had a tough year. That’s because during Covid-19 many elective medical procedures were postponed. However, I see this as a short-term setback. As vaccines are rolled out globally, elective procedures should pick up, boosting Smith & Nephew’s sales. This year, analysts expect sales to rise about 16%.

Looking further out, there’s an attractive growth story here. By 2030, it’s expected there’ll be 1.4bn people across the world aged 60 and over (versus less than 1bn now). This demographic shift should drive demand for joint replacements.

This stock could be volatile in the short term as Covid-19 cases fluctuate. In February, the company said there’s uncertainty regarding the timing and pace of the recovery.

However, I believe if I’m patient, I’ll be rewarded here. It’s worth noting that Barclays just raised its target price to 1,875p from 1,750p. That’s about 33% higher than the current share price.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Edward Sheldon owns shares in Diageo and Starbucks. The Motley Fool UK owns shares of and has recommended Starbucks. The Motley Fool UK has recommended Diageo and recommends the following options: short April 2021 $110 calls on Starbucks. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.